分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Structural insight into the assembly and D antigenicity of polio type 1 stabilized virus-like particles

Hong Qin, Chen Tian, Han Wenyu, Wang Shuxia, Lian Chaoyang, Zhang Yujie, Ruan Lizhu, Wang Tingfeng, Lin Cheng, Song Congcong, Liu Qingwei, Wang Xiaoli, Cong Yao, Huang Zhong

Journal:npj Vaccines

IF:6.5

DOI:10.1038/s41541-026-01404-0

PMID:

Published:2026-02-24

research field:免疫学结构生物学分子工程疫苗研发病毒学

Abstract

The inherent instability of poliovirus capsids presents a formidable challenge for developing next-generation vaccines suitable for a post-eradication world. Here, we address this by engineering a thermally stabilized virus-like particle (sVLP) derived from the poliovirus serotype 1 (PV1) Mahoney-SC7 mutant and elucidating its atomic-level structure. Produced at remarkably high yields in Pichia pastoris yeast, our engineered sVLP maintains a native, D-antigenic conformation and elicits a potent neutralizing antibody response in mice, in sharp contrast to unstable wild-type VLP (wtVLP) which adopts an expanded, non-immunogenic form. Our 2.43 Å resolution cryo-EM structure reveals precisely how seven stabilizing mutations cooperatively enhance inter-protomer contacts and rigidify surface loops to lock the particle in its immunogenic state. We further define a critical D-antigenic epitope by determining the 2.60 Å structure of the sVLP in complex with a novel D-antigen-specific, neutralizing monoclonal antibody, 3G10, elucidating the structural mechanisms of D-antigen recognition and virus neutralization by 3G10. These findings provide a definitive structural blueprint for engineering stable, immunogenic vaccines for PVs and other enteroviruses and also deliver a vital reagent for ensuring vaccine quality control.

购物车
客服
转染试用